Improved approaches for particulate characterization in biotherapeutics

このウェビナーを視聴するにはログインしてください

まだ登録されていませんか? アカウントを作成する
00:00:00 Welcome
00:01:22 Improved approaches for particulate characterization in biotherapeutics
00:02:19 Particulate Characterization – What particulates?
00:04:48 Protein Aggregates – General
00:06:29 Protein Aggregates – General Characteristics
00:08:10 Protein Aggregates (& Foreign Matter) – Importance
00:09:12 Protein Aggregates – What techniques are in use?
00:11:45 Morphologi G3SE-ID
00:13:11 Morphologi G3-ID- Identification of Sub-visible Particles in Suspended Bioformulations
00:14:22 Novel approach – thin path wet cell
00:14:28 Thin-Path Wet Cell* – Details
00:16:41 Test Sample – IVIg Suspension
00:18:18 Particle Count Results – IVIg Suspension
00:18:59 Particle Count Results – IVIg Suspension
00:19:20 Particle Identification Results – IVIg Suspension
00:22:28 Particle Identification Results – IVIg Suspension
00:23:28 Novel approach – Glass membrane filter
00:23:38 Glass Membrane Filter* – Details
00:25:45 Test Sample – IV Bolus with IVIg Suspension
00:27:02 Particle Count Results – IV and IVIg on Filter
00:28:11 Particle Identification Results – Filtered IV and IVIg
00:29:04 Particle Identification Results – Filtered IV and IVIg
00:30:44 Particle Identification Results – Filtered IV and IVIg
00:31:48 Wet Cell and Filter – Comparison Summary
00:33:32 Conclusions
00:34:53 Thank you for your attention
00:40:36 Contact Information

Product quality and safety concerns have driven the enumeration of particulate species in injectable products. Guidelines, such as USP<787>, <788>, and <790>, describe methods for collecting accurate particle count and size data in the sub-visible and visible ranges, and call for the use of microscopic techniques, among others. However, absolute identification of particulates is not currently required, even though such information can be inherently critical to root cause analysis. Hybrid automated microscopic-spectroscopic systems are capable of providing both particulate enumeration and identification well into the sub-visible range, extending the potential of routine counting to include explicit chemistry. This webinar will discuss improvements in sample presentation for both suspended and filtered samples, and provide application examples of biotherapeutic relevance using these new methods.